Sign in
IB

INTEGRATED BIOPHARMA INC (INBP)·Q3 2025 Earnings Summary

Executive Summary

  • Q3 FY2025 revenue rose 6.1% year over year to $13.95M, with gross margin expanding to 11.1% and diluted EPS improving to $0.02, reflecting stronger operating leverage versus the prior year .
  • Sequentially, revenue increased from $12.61M in Q2 to $13.95M in Q3 and operating margin expanded from 1.6% to 5.3%, indicating improved mix and cost discipline .
  • Management continues to highlight progress on customer diversification; the share of revenue from the two largest customers fell to 83% for the nine months ended March 31, 2025 (from 90% a year ago) though concentration remains high .
  • No formal guidance was issued and no earnings call transcript was available; press releases remain the primary source of commentary, with macro risks (inflation, tariffs, labor markets) cited as ongoing factors .

What Went Well and What Went Wrong

What Went Well

  • Revenue growth and margin expansion: Q3 revenue up 6.1% YoY to $13.95M and gross margin improved to 11.1%, driving operating income to $0.74M and net income to $0.61M .
  • Operating leverage: Operating margin increased to 5.3% in Q3 from 3.6% in Q1 and 1.6% in Q2, reflecting improved cost structure and mix .
  • Customer diversification momentum: “Our revenues increased by 6.9%... we were able to expand our customer base over the past year and increase our revenue,” per Co-CEOs Riva Sheppard and Christina Kay (nine months ended March 31, 2025) .

What Went Wrong

  • Customer concentration remains elevated: Two largest customers accounted for ~83% of nine-month revenue (down from 90% YoY), and were 85% of Q1 quarter revenue, underscoring ongoing dependency risk .
  • Limited forward visibility: No guidance ranges provided; commentary is high level, with macro risks cited (inflation, tariffs, tightened labor markets), constraining estimate frameworks .
  • Volatility around profitability: Subsequent quarter (Q4 FY2025) posted a net loss despite higher revenue, highlighting sensitivity to cost and mix shifts .

Financial Results

Quarterly Comparison (oldest → newest)

MetricQ1 FY2025 (Sep 30, 2024)Q2 FY2025 (Dec 31, 2024)Q3 FY2025 (Mar 31, 2025)
Revenue ($USD Millions)$13.62 $12.61 $13.95
Gross Profit ($USD Millions)$1.37 $1.17 $1.55
Gross Margin %10.1% 9.3% 11.1%
Operating Income ($USD Millions)$0.49 $0.20 $0.74
Operating Margin %3.6% 1.6% 5.3%
Net Income ($USD Millions)$0.26 $0.12 $0.61
Net Income Margin %1.9% 0.9% 4.4%
Diluted EPS ($USD)$0.01 $0.00 $0.02

Year-over-Year: Q3 FY2025 vs Q3 FY2024

MetricQ3 FY2024 (Mar 31, 2024)Q3 FY2025 (Mar 31, 2025)
Revenue ($USD Millions)$13.15 $13.95
Gross Profit ($USD Millions)$1.25 $1.55
Gross Margin %9.5% 11.1%
Operating Income ($USD Millions)$0.36 $0.74
Operating Margin %2.7% 5.3%
Net Income ($USD Millions)$0.29 $0.61
Diluted EPS ($USD)$0.01 $0.02

Estimates vs Actual (S&P Global)

MetricConsensus (S&P Global)*Actual Q3 FY2025
Revenue ($USD Millions)N/A*$13.95
Diluted EPS ($USD)N/A*$0.02

Values retrieved from S&P Global.*

KPIs

KPIQ1 FY2025Q2 FY2025 (Six Months)Q3 FY2025 (Nine Months)
Share of revenue from two largest customers (%)85% 82% 83%

Guidance Changes

MetricPeriodPrevious GuidanceCurrent GuidanceChange
RevenueFY2025/FY2026NoneNoneMaintained (no formal guidance)
Margins/OpEx/TaxFY2025/FY2026NoneNoneMaintained (no formal guidance)

Management did not issue quantitative guidance ranges in the Q3 FY2025 press release .

Earnings Call Themes & Trends

TopicPrevious Mentions (Q1 & Q2)Current Period (Q3)Trend
Customer concentration & diversification“Our goal of diversifying our customer base...” (Q1); 82% from two largest customers over six months (Q2) 83% from two largest customers over nine months (Q3); continued focus on expanding customer base Improving slowly but remains elevated
Macro: inflation, tariffs, labor marketsRisks cited including inflation, labor markets, geopolitical conflicts (Q1/Q2) Inflation and tariff pressures reiterated (Q3) Persistent caution
Supply chain/portsRisk of East Coast port strike noted in Q1 Not highlighted in Q3 Fading in commentary
Regulatory/legalGeneral regulatory risk disclosure (Q1/Q2) Regulatory changes cited as ongoing risk (Q3) Stable baseline risk

Note: No earnings call transcript was available; themes reflect press release disclosures .

Management Commentary

  • “Our revenues increased by 6.9% in the nine months ended March 31, 2025... we were able to expand our customer base over the past year and increase our revenue” — Co-CEOs Riva Sheppard and Christina Kay .
  • “Our goal of diversifying our customer base is reflected in our September quarter numbers from 91% in 2023 to 85% in 2024. We hope to continue this trend as well as grow with our current customers” — Co-CEOs (Q1 FY2025) .
  • Macro caution: inflation, tariffs, tightened labor markets, and regulatory changes referenced in forward-looking statements (Q3 FY2025) .

Q&A Highlights

  • No earnings call transcript found; no Q&A disclosures were available in our sources. The company’s IR site lists press releases but shows no upcoming events and provides no transcript link .

Estimates Context

  • S&P Global shows no active Wall Street consensus for Q3 FY2025 EPS or revenue; coverage appears unavailable for INBP at this time*. Results should be evaluated without an estimates benchmark. Values retrieved from S&P Global.*
  • Given the lack of formal guidance and consensus, model updates should emphasize observed sequential margin gains and the trajectory of customer concentration .

Key Takeaways for Investors

  • Sequential operating improvements: Q3 operating margin rose to 5.3% from 1.6% in Q2, with EPS improving to $0.02, indicating better execution and mix in core contract manufacturing .
  • YoY strength: Revenue +6.1% YoY and net income more than doubled to $0.61M, supported by gross margin expansion to 11.1% .
  • Concentration risk persists: Two largest customers still represent ~83% of year-to-date revenue; diversification progress should remain a focal point in underwriting .
  • No guidance and limited Street coverage: Absence of formal guidance and lack of consensus estimates increase uncertainty; rely on sequential trends and operational KPIs for near-term positioning .
  • Macro sensitivity: Inflation/tariffs and labor market tightness remain stated risks; monitor cost dynamics and potential pass-throughs in contract terms .
  • Watch subsequent quarter volatility: Q4 FY2025 net loss despite higher revenue highlights sensitivity to costs and customer order timing; treat Q3 improvements cautiously in near-term forecasts .
  • Near-term trading implication: Positive Q3 momentum with margin gains could be supportive, but high customer concentration and macro overhangs argue for balanced risk management until diversification further improves .